Physician profile
David Thompson
NPI 1548755150
$5,559.52
in general payments reported to CMS, 2019-2025
10 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.20 · 2022: $1,311 · 2023: $2,945 · 2024: $890 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041 · Travel and Lodging: $1,947 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.80 |
| Travel and Lodging | $1,947.40 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,691.33 | 2023-2025 | Evos, Trigen, Taylor Spatial Frame |
| Cgg Medical INC | $1,386.11 | 2022-2025 | |
| Arthrex, INC. | $493.12 | 2024 | |
| Stryker Corporation | $368.40 | 2022-2024 | Aequalis Perform Reversed, Gamma, Knotilus Anchor, 3.5mm |
| Depuy Synthes Sales INC. | $259.78 | 2024-2025 | Tfn-Advance, Na, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $224.58 | 2023-2024 | Ncb, Taperloc, G7 |
| Illuminoss Medical, INC. | $39.43 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Merz Pharmaceuticals, LLC | $34.03 | 2024 | Xeomin |
| Next Science LLC | $22.16 | 2023 | Blastx, Surgx, Xperience |
| Astrazeneca Pharmaceuticals LP | $19.38 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.